KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

HealthCare Royalty Partners, a private equity firm that invests in drug royalties and other health care-related investments, has rounded up $1.02 billion for its third fund, according to a filing ...

Clarke Futch, co-founder and managing partner of health care investment firm HealthCare Royalty Partners, poses for a photo inside his office at 300 Atlantic St., in downtown Stamford, Conn., on ...

Contacts HealthCare Royalty Partners Carlos Almodovar, 203-487-8311 [email protected] ...

4 March 2014 A - A + 100% Invuity, which develops medical devices, has raised $36 million in a Series E funding round led by HealthCare Royalty Partners. Additional investors in the round include ...

Publicly traded pharmaceutical company Adamas Pharmaceuticals Inc. said it entered into a $100 million royalty-backed note agreement with HealthCare Royalty Partners. Adamas in a press release ...

Contacts HealthCare Royalty Partners Carlos Almodovar, 203-487-8311 [email protected] ...